Global  

Debate heats up over using an anti-malaria drug for COVID-19

SeattlePI.com Monday, 6 April 2020
WASHINGTON (AP) — President Donald Trump and members of his administration are growing emphatic in promoting an anti-malaria drug not yet officially approved for fighting COVID-19, even though scientists say more testing is needed before it’s proven safe and effective against the virus.

Trump trade adviser Peter Navarro promoted the drug, hydroxychloroquine, in television interviews Monday, a day after Trump publicly put his faith in the drug to lesson the toll of the coronavirus pandemic.

“What do I know, I’m not a doctor," Trump told reporters Sunday. "But I have common sense.”

The administration's promotion of the drug comes after a heated Situation Room meeting of the White House's coronavirus task force on Saturday, in which Navarro challenged the top U.S. infectious disease expert, Dr. Anthony Fauci, over his concerns about recommending the drug based only on unscientific anecdotal evidence.

Navarro, who has no formal medical training, erupted at Fauci, raising his voice and claiming that the reports of studies he collected were enough to recommend the drug widely, according to a person familiar with the exchange who spoke on the condition of anonymity to describe the Situation Room blow-up.

Fauci has repeatedly said that current studies provide only anecdotal findings that the drug works. Navarro told CNN on Monday: "I would have two words for you: ‘second opinion.’”

Hydroxychloroquine is officially approved for treating malaria, rheumatoid arthritis and lupus, but not COVID-19. Small, preliminary studies have suggested it might help prevent the new coronavirus from entering cells and possibly help patients clear the virus sooner.

Two reports gave mixed results. A series of 11 patients in France found that an antibiotic-malaria drug combo did...
0
shares
ShareTweetSavePostSend
 
Video credit: ABC Action News - Published
News video: 1 million doses of anti-malaria drug heading to Florida for coronavirus patients

1 million doses of anti-malaria drug heading to Florida for coronavirus patients 01:13

One million doses of a drug used to treat malaria and lupus are being shipped to Florida to treat coronavirus patients, Governor Ron DeSantis announced on Tuesday. Story: https://wfts.tv/2XkxqyQ

Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine [Video]

US Hospitals Cut Back On Use Of Hydroxychloroquine

President Donald Trump promoted hydroxychloroquine, a malaria drug, as a COVID-19 treatment. According to Reuters, several studies suggest the drug isn’t effective against COVID-19 and creates..

Credit: Wochit     Duration: 00:32Published
WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 [Video]

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 The move comes after a report linked the drug to an increased fatality rate among those with coronavirus. The study in medical journal 'The..

Credit: Wibbitz Top Stories     Duration: 01:30Published

Related news from verified sources

Bureau of Prisons, VA purchase tens of thousands of dollars worth of anti-malaria drug amid coronavirus crisis

As the debate over the efficacy of using an anti-malaria drug to treat COVID-19 patients continues, two federal agencies reportedly purchased tens of thousands...
FOXNews.com Also reported by •Seattle Times

The hydroxychloroquine debate: Why is the malaria drug in the news and what do we know about it?

The anti-malaria drug hydroxychloroquine and its effectiveness against COVID-19 is stirring up more drama in the White House.
USATODAY.com

You Might Like


Tweets about this